Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5601–5650 of 34704
Jay Giraud, Karan Sodhi, Shashi Tripathi, Bal Bhullar and Melanie Figueroa were appointed as members of the board of directors
On November 14, 2024, Willy Verhaegen, a director of Mobile Global Esports, Inc., resigned as a director for personal reasons.
On November 15, 2024, the Board of Directors (the “Board”) of Rumble Inc. (the “Company”) appointed Jerry Naumoff to serve as a director on the Board, effective immediately.
On November 18, 2024 , the Board of Directors (the “Board”) of GameStop Corp. (the “Company”) increased the size of the Board from five to six members and appointed Nathaniel Turner as a director of the Company with a term expiring at the Company's 2025 Annual Meeting of Stockholders.
On November 15, 2024, Ms. Rose Marie Kadende Kaiser, PhD (“Ms. Rose, PhD) was appointed as an independent director of the Board to fill the vacancy left by Dr Vong, PhD’s resignation.
Effective as of November 14, 2024, Michaela Griggs and Don Gagliano resigned from the Board of the Company
Effective as of November 14, 2024, Michaela Griggs and Don Gagliano resigned from the Board of the Company
The Board also appointed Dr. Davis to the Board, effective November 18, 2024, to serve as a Class III director
elected Ron Hundzinski to fill the vacancy created by this increase in size of the Board of Directors.
On November 18, 2024, the Board of Directors (the “Board”) of Cibus, Inc. (the “Company”) appointed August Moretti to serve as a member of the Board, effective as of such date.
On November 15, 2024, Mark Castaneda notified the Board of Directors (the “Board”) of Gold Flora Corporation (the “Company”) that he will resign as a member of the Board and its committees, effective as of November 30, 2024.
Effective on November 12, 2024, in connection with the effectiveness of the Registration Statement, James Jiayuan Tong, Qian (Hebe) Xu, and Tianchen Cai became directors of the Company.
Effective on November 12, 2024, in connection with the effectiveness of the Registration Statement, James Jiayuan Tong, Qian (Hebe) Xu, and Tianchen Cai became directors of the Company.
Effective on November 12, 2024, in connection with the effectiveness of the Registration Statement, James Jiayuan Tong, Qian (Hebe) Xu, and Tianchen Cai became directors of the Company.
On November 14, 2024, the Board of Directors (the “Board”) of Valley National Bancorp (the “Company”) appointed Nitzan Sandor as a director of the Company
On November 11, 2024, the Board of Directors (the “ Board ”) of Apollo Asset Backed Credit Company LLC (the “ Company ”) (i) voted to increase the size of the Board to eight directors, (ii) appointed Michael Paniwozik and Thomas Marano to fill the resulting vacancies, and (iii) appointed Mr. Marano to the Audit Committee of the Board, each effective November 11, 2024.
On November 11, 2024, the Board of Directors (the “ Board ”) of Apollo Asset Backed Credit Company LLC (the “ Company ”) (i) voted to increase the size of the Board to eight directors, (ii) appointed Michael Paniwozik and Thomas Marano to fill the resulting vacancies, and (iii) appointed Mr. Marano to the Audit Committee of the Board, each effective November 11, 2024.
On November 12, 2024, Matthew D’Ambrosio resigned as a member of the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”), the Compensation Committee of the Board, and the Quality, Compliance, and Governance Committee of the Board, effective as of November 12, 2024.
Kim Dougherty age (62) was elected as a new member of the Board of Directors of Pismo Coast Village, Inc. effective November 9, 2024.
the resignation of Wayne E. Hardesty at the Pismo Coast Village Board meeting held on September 17, 2024.
the Board of Directors of First Foundation Inc. (the “Company”) appointed C. Allen Parker as a director, effective immediately.
On November 13, 2024, the Board of Directors (the “Board”) of Hyster-Yale, Inc. (the “Company”) increased the size of the Board from fourteen to fifteen members and elected Ann O’Hara as Director of the Company, effective immediately (the “Effective Date”).
Mr. Daniel C. Wicker, a director of each of Tectonic Financial, Inc. (the “Company”), the Company’s wholly owned subsidiary, T Bancshares, Inc. (“TBI”), and TBI’s wholly owned subsidiary, T Bank, National Association (the “Bank”), notified the Boards of Directors of the Company, TBI and the Bank (collectively, the “Boards”) of his decision to retire from the Boards effective December 31, 2024.
appointed each of Gwendolyn Hatten Butler, Trisha Miller, Glenn Rufrano and Simon M. Turner to the board of directors to fill the vacancies created by such increase, in each case, effective immediately.
appointed each of Gwendolyn Hatten Butler, Trisha Miller, Glenn Rufrano and Simon M. Turner to the board of directors to fill the vacancies created by such increase, in each case, effective immediately.
appointed each of Gwendolyn Hatten Butler, Trisha Miller, Glenn Rufrano and Simon M. Turner to the board of directors to fill the vacancies created by such increase, in each case, effective immediately.
appointed each of Gwendolyn Hatten Butler, Trisha Miller, Glenn Rufrano and Simon M. Turner to the board of directors to fill the vacancies created by such increase, in each case, effective immediately.
Pursuant to the terms of Mr. Myers’ employment agreement, upon termination, Mr. Myers is deemed to have resigned as a member of the Board of Directors of the Company.
Effective November 12, 2024, Anne Townsend voluntarily resigned from her position as a member of the board of directors (the “Board”) of Rekor Systems, Inc. (the “Company”) in order to pursue personal commitments.
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the "Company") , effective immediately.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Vance R. Brown and Jonathan R. Monson, comprising all of the members of the board of directors of Merger Sub as of immediately prior to the Effective Time, became a member of the Company’s board of directors.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Vance R. Brown and Jonathan R. Monson, comprising all of the members of the board of directors of Merger Sub as of immediately prior to the Effective Time, became a member of the Company’s board of directors.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
Pursuant to the Merger Agreement, effective as of the Effective Time, each of Michael H. Carrel, Raymond W. Cohen, David M. Demski, Jane E. Kiernan, Esteban López, M.D., Robert E. McNamara, and Nancy L. Snyderman, M.D., FACS, comprising all of the members of the Company’s board of directors, ceased serving as a member of the Company’s board of directors and each committee thereof.
elected Dominick Schiano to the Board to fill the vacancy created by an increase in the size of the Board from eight to nine members
On November 14, 2024, the Board of Directors of MDU Resources Group, Inc. (the “Company”) elected Vernon A. Dosch as a director of the Board, effective November 15, 2024, to serve until the 2025 Annual Meeting of Stockholders.
Effective on the same date, Dr. Sandler resigned as a member of the Board and all committees thereof.
Hoyoung Huh, MD, PhD, James Neal and Sandip Patel resigned as directors of the Company and any committees thereof.
Hoyoung Huh, MD, PhD, James Neal and Sandip Patel resigned as directors of the Company and any committees thereof.
Hoyoung Huh, MD, PhD, James Neal and Sandip Patel resigned as directors of the Company and any committees thereof.
As previously disclosed, effective as of the Effective Time and pursuant to the terms of the Merger Agreement, the Akari Board appointed Hoyoung Huh, M.D., Ph. D, James Neal and Sandip Patel, each of whom were members of the board of directors of Peak Bio, to serve as directors for a term commencing upon the Effective Time.
Wa’el Hashad and Donald Williams resigned as directors of Akari and any committees thereof.
Wa’el Hashad and Donald Williams resigned as directors of Akari and any committees thereof.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.